Home » Topics » BioWorld Science

BioWorld Science
RSS

Millennium continues momentum during Q2 2001

July 20, 2001

Mechanism of action of Mylotarg in AML elucidated

July 20, 2001

New erectile dysfunction therapy now available in U.K.

July 20, 2001

Antiproliferative vitamin D analogues from Galderma particularly useful in dermatology

July 19, 2001

Hormos presents new series of SERMs and their potential uses

July 19, 2001

Opioid receptor ligands designed by Palatin

July 19, 2001

2-Arylquinolines selectively relax urethral smooth muscle according to recent patent

July 19, 2001

Antibacterial agents with additional pharmacological properties developed at Antex Pharma

July 19, 2001

Therapy of psoriasis with anti-TNF-alpha antibodies

July 19, 2001

XTL and Dong Wha enter hepatitis C alliance

July 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.